Drug details

Myxredlin (insulin regular human)

type of Antidiabetics, Insulins, Antidiabetics, Short-Acting Insulins

Myxredlin (insulin human in sodium chloride injection) is a short-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

This drug may have the following side effects:

• allergic reactions,
• fluid retention (edema)
• weight gain, and
• low blood sugar (hypoglycemia),

The following drugs are related to Myxredlin, either as a replacement or used together:

• Amaryl Tablets (glimepiride)
• Lantidra (donislecel-jujn allogeneic pancreatic islet cellular)
• Glucotrol (glipizide)
• Glucotrol XL (glipizide extended release)
• Glucophage, Glucophage XR (metformin hcl)
• Glucovance (glyburide and metformin)
• Glumetza (metformin hcl)
• Tresiba (insulin degludec injection)
• Tradjenta (linagliptin)